1 results match your criteria: "Minnesota 3 Oregon Clinic[Affiliation]"
Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
Dis Colon Rectum
December 2016
1 Division of Colon and Rectal Surgery, Department of Surgery, Mayo Clinic, Rochester, Minnesota 2 Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Healthcare Delivery, Rochester, Minnesota 3 Oregon Clinic, Portland, Oregon.
Background: Clinical trials demonstrate that postresection chemotherapy conveys survival benefit to patients with stage III colon cancer. It is unclear whether this benefit can be extrapolated to the elderly, who are underenrolled in clinical trials.
Objective: The purpose of this study was to determine outcomes of selected octogenarians with stage III colon cancer with/without postresection adjuvant therapy.